Abstract:Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, has a close pathophysiological association with energy metabolism [ 1 Nguyen T.N. Hilmer S.N. Cumming R.G. Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol. 2013; 167: 2412-2420 Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar , 2 Tu T. Zhou S. Liu Z. Li X. Liu Q. Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation. Circ J. 2014; 78: 993-1001 Crossref PubMed Scopus (41) Google Scholar ]. Impaired atrial myocardial energy status has been demonstrated in atrial tissue of animal AF models and AF patients [ 2 Tu T. Zhou S. Liu Z. Li X. Liu Q. Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation. Circ J. 2014; 78: 993-1001 Crossref PubMed Scopus (41) Google Scholar , 3 Kalifa J. Maixent J.M. Chalvidan T. Dalmasso C. Colin D. Cozma D. et al. Energetic metabolism during acute stretch-related atrial fibrillation Mol Cell Biochem. 2008; 317: 69-75 Google Scholar , 4 Sun D.M. Yuan X. Wei H. Zhu S.J. Zhang P. Zhang S.J. et al. Impaired myocardium energetics associated with the risk for new-onset atrial fibrillation after isolated coronary artery bypass graft surgery. Coron Artery Dis. 2014; 25: 224-229 PubMed Google Scholar ]. The performances of impaired energy status related to reduction of adenine nucleotides, a depletion of high energy phosphates, reduced activities of energy metabolism enzymes, decreasing in the cellular energy potential and alteration of regulator in mitochondrial oxidative metabolism [ 2 Tu T. Zhou S. Liu Z. Li X. Liu Q. Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation. Circ J. 2014; 78: 993-1001 Crossref PubMed Scopus (41) Google Scholar , 3 Kalifa J. Maixent J.M. Chalvidan T. Dalmasso C. Colin D. Cozma D. et al. Energetic metabolism during acute stretch-related atrial fibrillation Mol Cell Biochem. 2008; 317: 69-75 Google Scholar , 4 Sun D.M. Yuan X. Wei H. Zhu S.J. Zhang P. Zhang S.J. et al. Impaired myocardium energetics associated with the risk for new-onset atrial fibrillation after isolated coronary artery bypass graft surgery. Coron Artery Dis. 2014; 25: 224-229 PubMed Google Scholar ]. As the cellular “hubs” for adenosine triphosphate (ATP) production and redox homeostasis, mitochondria exert a profound effect on the cardiomyocyte energy metabolism and the electromechanical function of the heart. Given the multiple involvements in cellular metabolic pathways, it is not surprising that there is convincing evidence that mitochondrial dysfunction can lead to the development of arrhythmia [ [5] Brown D.A. O'Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res. 2010; 88: 241-249 Crossref PubMed Scopus (155) Google Scholar ]. One recent study has shown the close association between the mitochondrial dysfunction of the atrial myocardium and AF and supported a clear link between mitochondrial dysfunction and AF [ [6] Montaigne D. Marechal X. Lefebvre P. Modine T. Fayad G. Dehondt H. et al. Mitochondrial dysfunction as an arrhythmogenic substrate: a translation proof-of concept study in patients with metabolic syndrome in whom post operative atrial fibrillation develops. J Am Coll Cardiol. 2013; 62: 1466-1473 Abstract Full Text Full Text PDF PubMed Scopus (98) Google Scholar ].

Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions

Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach

Mitochondria and the Pathophysiological Mechanism of Atrial Fibrillation.

Mitochondrial Dysfunction Underlies Cardiomyocyte Remodeling in Experimental and Clinical Atrial Fibrillation

Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications

Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal.

Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track

Quantitative 3D electron microscopy characterization of mitochondrial structure, mitophagy, and organelle interactions in murine atrial fibrillation

Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective

Attenuating persistent sodium current–induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress

Mitochondrial reactive oxygen species and atrial fibrillation

A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation

Acetylation: A Potential “regulating Valve” of Cardiac Energy Metabolism During Atrial Fibrillation

Mitochondrial Hyperfusion during Oxidative Stress Is Coupled to a Dysregulation in Calcium Handling within a C2C12 Cell Model

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Disruption of Sarcoplasmic Reticulum-Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2

Multiple targets related to mitochondrial function unveiled by metabolomics and proteomics profiles of hearts from atrial fibrillation patients

Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy